Profesionales médicos

A continuación, se enumeran los ensayos clínicos actuales.

Filtra esta lista de estudios por sede, estado, etc.

1. A Study to Compare ADalimumab vs. Conventional ImmunoSupprEssion for Uveitis

   Rochester, Minn.

   The primary purpose of this study is to compare the relative effectiveness of adalimumab vs. conventional immunosuppression at controlling ocular inflammation while permitting tapering of prednisone to < 7.5 mg/day.

2. A Study to Evaluate the Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients

   Jacksonville, Fla.

   The purpose of this study is to evaluate the clinical outcomes of the Micropulse Trans-Scleral Cyclophotocoagulation Laser (MPTSCPC) after 1 day, 1 week,1 month, 3 months, 6 months and one year of follow-up. Its primary objective is to conduct a prospective observational study on the efficacy of using MP-TSCPC to treat glaucoma patients.

3. Artisan Aphakia Lens for the Correction of Aphakia in Children

   Rochester, Minn.

   The purpose of this study is to determine the safety and effectiveness of the Artisan Aphakia Lens in the treatment of aphakia in children.

4. A Study to Determine if the Fluid that Collects in the Retina (Macular Edema) Changes Throughout the Course of a Single Day

   Rochester, Minn.

   The purpose of this study is to determine if the fluid that collects in your retina, known as macular edema, changes throughout the course of a single day. If it does, this may change how the disease is treated in the future.

5. Collaborative Study on Optic Neuritis and Autoantibodies Affecting the Eye

   Rochester, Minn.

   The study proposes to form a consortium of autoimmunity of the optic nerve with the goal of improving diagnosis and treatment of these conditions. 

6. Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

   Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz.

   This phase II trial studies how well glembatumumab vedotin works in treating patients with middle layer of the wall of the eye (uveal) melanoma that has spread to other parts of the body (metastatic) or has returned at or near the same place after a period of time during which the cancer could not be detected (locally recurrent). Glembatumumab vedotin may shrink the tumor by binding to tumor cells and delivering tumor-killing substances to them.

7. A Study of Cognitive Function in Patients with Macular Degeneration

   Rochester, Minn.

   The purpose of this study is to determine the prevalence and severity of cognitive dysfunction in patients with wet and dry macular degeneration.

8. Early Detection of Glaucomatous Optic Neuropathy

   Rochester, Minn.

   The goal of this study is to determine if visual field assessment of the far periphery (60-4) and/or central visual field (10-2) enables earlier detection of  glaucomatous optic neuropathy.

9. Zoster Eye Disease Study

   Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz.

   This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.

10. A Natural History Observation and Registry Study of Macular Telangiectasia Type 2: The MacTel Study

    Rochester, Minn.

    The purpose of this study is to develop a Registry of participants with MacTel Type 2 (as confirmed by the Reading Center) who may agree to be contacted for inclusion in future clinical trials. The Registry participants include new participants and participants from the NHO, Genetic I and Genetics II studies who agree to continue to participate. 

    The second objective is to continue to identify whether there is a genetic link associated with MacTel Type 2. All participants who have not previously provided a blood sample will be given the option to provide a blood sample for genetic sequencing.